Rising US consumer inflation, particularly from gas prices, could impact consumer discretionary spending on medical devices like Dexcom's CGM systems, potentially affecting adoption rates or sales volumes if consumers face tighter budgets.

A mixed US labor market picture creates economic uncertainty, which might lead to more cautious consumer spending on healthcare, including new medical technologies. This could indirectly influence Dexcom's domestic growth prospects.

While the easing Middle East conflict primarily affects global stability and energy markets, reduced geopolitical tension generally fosters a more favorable investment climate for growth-oriented healthcare technology companies, potentially impacting investor sentiment towards DXCM.